Sorted By:

Relevance


Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients

PhRMA  |  Blog Post

Learn more about why drug importation is bad for patients here.
http://catalyst.phrma.org/discovery-of-counterfeit-hepatitis-c-drug-is-another-example-of-why-importation-is-bad-for-patients

Clinical Trials

PhRMA  |  From PhRMA

Explore the interactive map below and select a state to access data on biopharmaceutical jobs, the industry's overall economic impact, clinical trial activity, and more. 
http://www.phrma.org/resources/state-map/clinical-trials

The Story of Pat Scannon, Chief Scientific Officer, Xoma

PhRMA  |  Video

." - The story of Pat Scannon, Chief Scientific Officer at Xoma.
http://www.phrma.org/video/the-story-of-pat-scannon-chief-scientific-officer-xoma

Getting What You Pay for in the ACA

Access Better Coverage  |  From Our Network

The Medicare Part D prescription drug program has such a feature, and it's proven hugely helpful to seniors.
http://www.accessbettercoverage.org/social-news/getting-what-you-pay-for-in-the-aca

New data put medicine costs and spending in context

PhRMA  |  Blog Post

Biopharmaceutical companies invested about $75 billion in research and development (R&D) in 2015 and, on average, reinvest 20 percent of revenues into R&D.
http://catalyst.phrma.org/new-data-put-medicine-costs-and-spending-in-context

Celebrating hope for patients and families on World Heart Day 2016

PhRMA  |  Blog Post

Patients like my grandfather may live longer, more productive lives because of it – and we can share in it, one heartbeat at a time.
http://catalyst.phrma.org/celebrating-hope-for-patients-and-families-on-world-heart-day-2016

Paul Gileno

PhRMA  |  Biography

In May 2014, he was the recipient of the Unsung Hero Award for his stellar work in pain policy initiatives as well as his significant contributions to advance the social awareness of pain and suffering.
http://www.phrma.org/biography/paul-gileno

She Has Health Insurance, But Can't Pay Her Medical Bills. She's Not Alone.

Access Better Coverage  |  From Our Network

She adds, "my car insurance may reimburse me for some of it after I'm done with treatment, but I don't know when that will be."
http://www.accessbettercoverage.org/social-news/she-has-health-insurance-but-cant-pay-her-medical-bills

New research: Insurance plan structure can have discriminatory effect

PhRMA  |  Blog Post

They note, “This insurance practice has the discriminatory effect of discouraging individuals in need of specific medications from enrolling in these plans or of shifting the burden of the cost back to these enrollees.
http://catalyst.phrma.org/new-research-insurance-plan-structure-can-have-discriminatory-effect

Mae Jemison

PhRMA  |  Biography

She is a highly sought after speaker on issues including health care, social responsibility, technology and motivation and has provided commentary for the BBC, McNeil Lehrer Report, ABC Nightline, NPR and CNN.
http://www.phrma.org/biography/mae-jemison

Many Say High Deductibles Make Their Health Law Insurance All but Useless

Access Better Coverage  |  From Our Network

I’m better off not purchasing that insurance and saving the money in case something bad happens.
http://www.accessbettercoverage.org/social-news/many-say-high-deductibles-make-their-health-law-insurance-all-but-useless

Medicare Monday: A closer look at Part B spending

PhRMA  |  Blog Post

While the Medicare Part B program helps ensure patients can access these complex, innovative medicines, it also works to moderate spending.
http://catalyst.phrma.org/medicare-monday-a-closer-look-at-part-b-spending

Medicare Monday: Part D premiums expected to drop in 2018

PhRMA  |  Blog Post

We must continue to protect this critical program so seniors and people living with disabilities can continue to live happy, healthy lives.
http://catalyst.phrma.org/part-d-premiums-expected-drop-2018

Ethicon-Endo Surgery v. Covidien Supreme court brief on the fairness of the IPR system at the PTO

PhRMA  |  Speeches & Communication

PhRMA Amicus brief filed to U.S. Supreme Court in support of Ethicon Endo-Surgery, Inc., in the case of Ethicon-Endo Surgery v. Covidien and Michelle K. Lee, Director, U.S. Patent and Trademark Office....
http://www.phrma.org/public-communication/supreme-court-brief-fairness-of-the-ipr-system-pto

Paul Fonteyne

PhRMA  |  Biography


http://www.phrma.org/biography/paul-fonteyne

Ian Read

PhRMA  |  Biography

Ian serves on the Board of Kimberly-Clark as well as on the U.S.
http://www.phrma.org/biography/ian-read1

Are new hep C treatments cost effective? Doctors say answer is “a resounding yes”

PhRMA  |  Blog Post

For more, be sure to check out: What They Are Saying about New Hep C Cure: “That's actually a great deal” ICYMI: Insurer: “Can drugs as expensive as these really be cost-effective?
http://catalyst.phrma.org/are-new-hep-c-treatments-cost-effective-doctors-say-answer-is-a-resounding-yes

Lisa M. Tate, CAE

PhRMA  |  Biography

Since her arrival in 2007, WomenHeart: The National Coalition for Women with Heart Disease has multiplied its collaborations with health providers, corporate partners and non-profit allies, enabling it to expand the number of community-based support groups, online patient support services and its unique, national network of WomenHeart Champions.
http://www.phrma.org/biography/lisa-m-tate-cae

Paul Aines

PhRMA  |  Biography

He started his career on the audit staff at professional services company KPMG LLP.
http://www.phrma.org/biography/paul-aines

Medicare Monday: A closer look at Medicare Part B

PhRMA  |  Blog Post

A recent report from the Department of Health and Human Services also found that spending on Part B medicines has remained a small share of overall Part B spending, with only moderate increases from 2007 to the present.
http://catalyst.phrma.org/medicare-monday-a-closer-look-at-medicare-part-b

ICYMI: Has the 340B Program Lost Its Way?

PhRMA  |  Blog Post

” Rapid growth of contract pharmacy arrangements.
http://catalyst.phrma.org/icymi-has-the-340b-program-lost-its-way

Medicare Monday: A refresh on private negotiation in Part D

PhRMA  |  Blog Post

CBO has also found that for the government to negotiate lower prices, it would have to place either access or coverage restrictions on medicines for Part D beneficiaries, stating “… the negotiating lever that’s used to lower drug prices is the threat of not allowing that drug to be prescribed or putting limitations on its being prescribed within that drug plan.”
http://catalyst.phrma.org/medicare-monday-a-refresh-on-private-negotiation-in-part-d

Medicare Monday: Who qualifies for Part D Extra Help?

PhRMA  |  Blog Post

Learn more about the program here.
http://catalyst.phrma.org/medicare-monday-who-qualifies-for-part-d-extra-help

Australia’s opportunity to lead the TPP forward

PhRMA  |  Blog Post

  In some cases innovative therapies may experience patent expiry shortly after making it to market, providing the innovator firm with little chance of recovering the investment that was required to develop the therapy.
http://catalyst.phrma.org/australia-s-opportunity-to-lead-the-tpp-forward

Medicare Monday: Who qualifies for Part D Extra Help?

PhRMA  |  Blog Post

Learn more about the program here.
http://catalyst.phrma.org/catalyst-dev/medicare-monday-who-qualifies-for-part-d-extra-help-0

You have reviewed the first 75 results out of 2122. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next